[{"AccountsPayableCurrent_0_Q1_USD":2839000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":734000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":394463000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-2617000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":51900882.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":12690000.0,"NonoperatingIncomeExpense_1_Q1_USD":-4898000.0,"EarningsPerShareBasic_1_Q1_USD":-0.41,"CostOfGoodsAndServicesSold_1_Q1_USD":819000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":21000.0,"InventoryWorkInProcess_0_Q1_USD":118000.0,"InventoryRawMaterials_0_Q1_USD":200000.0,"InventoryFinishedGoods_0_Q1_USD":789000.0,"IncreaseDecreaseInInventories_1_Q1_USD":153000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":51900882.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":128000.0,"ShareBasedCompensation_1_Q1_USD":1665000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":6098000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":128000.0,"SellingAndMarketingExpense_1_Q1_USD":7130000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.41,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":14103000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":2609000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":1764000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":6467000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":8590000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1181000.0,"InvestmentIncomeNet_1_Q1_USD":139000.0,"IncomeTaxExaminationPenaltiesAndInterestAccrued_0_Q1_USD":0.0,"DerivativeGainLossOnDerivativeNet_1_Q1_USD":-3404000.0,"PreferredStockValue_0_Q1_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-6285000.0,"DerivativeLiabilitiesNoncurrent_0_Q1_USD":15528000.0,"AmortizationOfFinancingCosts_1_Q1_USD":1048000.0,"IncreaseDecreaseInDerivativeLiabilities_1_Q1_USD":-3404000.0,"DerivativeLiabilities_0_Q1_USD":15528000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":25299000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1665000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":49916000.0,"LongTermNotesPayable_0_Q1_USD":22987000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1665000.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1_Q1_shares":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":72857000.0,"Liabilities_0_Q1_USD":83516000.0,"InventoryNet_0_Q1_USD":1107000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":234000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":881000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-236000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5176000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.41,"CostsAndExpenses_1_Q1_USD":19223000.0,"CommonStockValue_0_Q1_USD":5000.0,"CommonStockSharesOutstanding_0_Q1_shares":53037703.0,"CommonStockSharesIssued_0_Q1_shares":53037703.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":48152000.0,"AssetsCurrent_0_Q1_USD":55153000.0,"Assets_0_Q1_USD":72857000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":9311293.0,"AccountsReceivableNetCurrent_0_Q1_USD":3429000.0,"LiabilitiesCurrent_0_Q1_USD":11112000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":12818000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-249000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-18854000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingIncomeLoss_1_Q1_USD":-16614000.0,"NotesPayableCurrent_0_Q1_USD":2074000.0,"InterestPaidNet_1_Q1_USD":585000.0,"InterestExpense_1_Q1_USD":1633000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"PreferredStockSharesIssued_0_Q1_shares":0.0,"AccruedLiabilitiesCurrent_0_Q1_USD":5018000.0,"StockholdersEquity_0_Q1_USD":-10659000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-405127000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":9473000.0,"ProfitLoss_1_Q1_USD":-21512000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":12690000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2465000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":249000.0,"NetIncomeLoss_1_Q1_USD":-21512000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":51900882.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"Ticker":"OCUL","CIK":"1393434","name":"OCULAR THERAPEUTIX, INC","OfficialName":"Ocular Therapeutix Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"305481557.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200508"}]